Umbrella review of 21 meta-analyses (>160,000 patients) in metastatic prostate cancer: prostate radiotherapy improved OS in low-volume hormone-sensitive disease (pooled HR ≈0.64-0.73); metastasis-directed SBRT prolonged PFS (HR ≈0.48) with emerging OS benefit.
Meta-analysisn = 21 meta-analyses
Petrelli et al. Primary tumor and metastasis-directed treatment for oligometastatic prostate cancer: An umbrella review of meta-analyses